About Ipsen
Ipsen is a leading global biopharmaceutical company that specializes in innovation and specialty care. The company has a strong focus on developing new treatments for patients with unmet medical needs, and its mission is to leave no patient behind.
With a history dating back over 90 years, Ipsen has established itself as a trusted name in the pharmaceutical industry. The company operates in more than 30 countries worldwide, with a workforce of over 5,000 employees dedicated to improving the lives of patients around the world.
One of Ipsen's key strengths is its commitment to research and development. The company invests heavily in R&D each year, with the aim of discovering new treatments for diseases that currently have no cure or limited treatment options. This dedication to innovation has led to numerous breakthroughs in areas such as oncology, neurology, and rare diseases.
In addition to its focus on R&D, Ipsen also places great importance on collaboration. The company works closely with healthcare professionals and patient groups around the world to ensure that its products meet the needs of patients and are accessible to those who need them most.
Ipsen's portfolio includes a wide range of products across several therapeutic areas. In oncology, for example, the company offers treatments for various types of cancer including kidney cancer and neuroendocrine tumors. In neurology, Ipsen provides therapies for conditions such as spasticity associated with cerebral palsy or multiple sclerosis (MS). Additionally they offer solutions for rare diseases like acromegaly or thyroid eye disease (TED).
Overall, Ipsen is an innovative biopharmaceutical group committed to improving patient outcomes through cutting-edge research and development efforts combined with close collaboration between healthcare professionals and patient groups worldwide. With their strong focus on specialty care they are well positioned as leaders within their field - leaving no patient behind!